Keryx receives European approval for Fexeric (ferric citrate coordination complex) for the treatment of hyperphosphataemia in adults with chronic kidney disease

24 September 2015 - Keryx Biopharmaceuticals, Inc. today announced that the European Commission has approved Fexeric (ferric citrate coordination complex) for ...

Read more →

AcelRx Pharmaceuticals reports that the European Commission has granted marketing authorization for Zalviso for treatment of acute moderate-to-severe post-operative pain in adult patients

22 September 2015 - AcelRx Pharmaceuticals, Inc. announced today that the European Commission (EC) has approved Zalviso (15 micrograms sufentanil sublingual ...

Read more →

Non-stimulant for ADHD approved in Europe

21 September 2015 - Shire today announced that the European Commission granted Marketing Authorisation for once-daily, non-stimulant Intuniv (guanfacine hydrochloride prolonged ...

Read more →

Updated label for Daklinza (daclatasvir) for the 12-week treatment of non-cirrhotic patients with chronic hepatitis C genotype 3 approved by the European Commission

10 September 2015 - Bristol-Myers Squibb Company announced today that the European Commission has approved an updated label for Daklinza for ...

Read more →

Santhera receives European marketing authorisation for Raxone in Leber's hereditary optic neuropathy (LHON)

9 September 2015 - Santhera Pharmaceuticals announces the European Commission (EC) has granted marketing authorisation for Raxone as the first approved ...

Read more →

Novartis receives EU approval for Farydak, the first in its class of anticancer agents approved for patients with multiple myeloma

4 September 2015 - Novartis announced today that the European Commission has approved Farydak (panobinostat, previously known as LBH589) capsules, in ...

Read more →